Immucell Corp
ICCC- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000811641
No open-market purchases or sales by Immucell Corp insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $13.4M in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Immucell Corp as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 26
- 0 vs. Q3 2022
- Shares held
- 982.1K
- +10.7K (+1.1%) vs. Q3 2022
- Total value
- $5.41M
- −$1.86M (−25.6%) vs. Q3 2022
- New holders
- 1
- 5 more added
- Sold out
- 1
- 5 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ICCC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 31 | $13.4M |
| Q1 2026 | 27 | $8.67M |
| Q4 2025 | 26 | $7.87M |
| Q3 2025 | 27 | $8.08M |
| Q2 2025 | 25 | $9.00M |
| Q1 2025 | 27 | $5.79M |
| Q4 2024 | 27 | $6.21M |
| Q3 2024 | 22 | $4.27M |
| Q2 2024 | 28 | $5.56M |
| Q1 2024 | 25 | $5.39M |
| Q4 2023 | 28 | $5.31M |
| Q3 2023 | 30 | $5.47M |
| Q2 2023 | 31 | $5.32M |
| Q1 2023 | 30 | $5.42M |
| Q4 2022 | 26 | $5.41M |
| Q3 2022 | 26 | $7.26M |
| Q2 2022 | 29 | $8.53M |
| Q1 2022 | 27 | $9.18M |
| Q4 2021 | 29 | $7.04M |
| Q3 2021 | 28 | $8.05M |
| Q2 2021 | 28 | $7.45M |
| Q1 2021 | 28 | $7.20M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Immucell Corp; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 37 | $226 | 0.00% | 00.0% | Unchanged |
| Cresset Asset Management, LLC | 96,426 | $721 | 0.00% | 00.0% | Unchanged |
| Northwestern Mutual Wealth Management Co | 152 | $927 | 0.00% | 00.0% | Unchanged |
| Geneos Wealth Management Inc. | 244 | $1.49K | 0.00% | 00.0% | Unchanged |
| US Bancorp | 600 | $3.66K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,276 | $8.00K | 0.00% | +1,276 | New |
| UBS Group AG | 1,500 | $9.15K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 2,038 | $12.4K | 0.00% | +6+0.3% | Added |
| HM Payson & Co | 8,130 | $49.8K | 0.00% | 00.0% | Unchanged |
| Essex Financial Services, Inc. | 11,000 | $67.0K | 0.01% | 00.0% | Unchanged |
| Minerva Advisors LLC | 11,958 | $72.1K | 0.05% | 00.0% | Unchanged |
| Northern Trust Corp | 12,445 | $75.9K | 0.00% | −222−1.8% | Reduced |
| Flagship Harbor Advisors, LLC | 14,230 | $86.8K | 0.01% | −2,000−12.3% | Reduced |
| BlackRock Inc. | 15,596 | $95.1K | 0.00% | +324+2.1% | Added |
| Wealth Effects LLC | 15,650 | $95.5K | 0.05% | 00.0% | Unchanged |
| HighTower Advisors, LLC | 21,354 | $131.0K | 0.00% | 00.0% | Unchanged |
| Perritt Capital Management Inc | 30,000 | $183.0K | 0.10% | −6,494−17.8% | Reduced |
| Strategic Financial Services, Inc, | 31,000 | $189.7K | 0.02% | 00.0% | Unchanged |
| Overbrook Management Corp | 35,532 | $216.7K | 0.06% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 38,082 | $233.0K | 0.00% | −53−0.1% | Reduced |
| Shufro Rose & Co LLC | 62,408 | $380.7K | 0.03% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 62,170 | $381.0K | 0.00% | +39,591+175.3% | Added |
| Morgan Stanley | 76,874 | $468.9K | 0.00% | +2,800+3.8% | Added |
| Bleichroeder LP | 101,594 | $619.7K | 0.13% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 125,489 | $765.0K | 0.00% | −12,097−8.8% | Reduced |
| Vanguard Group Inc | 206,325 | $1.26M | 0.00% | +3,596+1.8% | Added |
| Prosperity Planning, Inc. | 0 | $0 | 0.00% | −16,000−100.0% | Sold out |